Provider review
AbundRX review
Its cards and its FAQ state the same two prices, and they agree.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
We may earn a commission at no extra cost to you. Affiliate partners are listed first on our rankings. How we’re funded.
$99 semaglutide and $149 tirzepatide, no period stated
Visit AbundRXNeither figure carries a billing period, so you know two numbers and not what either one buys.
Price as published
AbundRX
$99 semaglutide and $149 tirzepatide, no period stated
- Vs median
- Not comparable — no per-month rate is published — the verified string carries no monthly figure
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
The reason to note this one is consistency. Its two figures appear in the product cards and again in the FAQ, in the same words, agreeing exactly. That sounds like the minimum and it is not, because several sellers we have looked at contradict themselves between precisely those two places on the same page. What is missing here is the denominator. Neither figure carries a billing period — not a month, not a supply length, not a course — so you come away knowing two numbers and not knowing what either one buys. A separately advertised premium access unlock uses the same ninety-nine dollars for something else again, which makes the front page harder to read rather than easier. The care descriptions are hedged throughout in the language of what a treatment may do, and no milligram appears anywhere.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want the price in the card to match the price in the FAQ
- You want both figures visible without an intake
- You will ask what period the figure covers before paying
Look elsewhere if
- You want to know what the price actually buys. No period is stated
- You are confused by one number being used for two different things
- You want a dose behind the number
What it actually costs
Price as published
$99 semaglutide and $149 tirzepatide, no period stated
- Vs median
- Not comparable — no per-month rate is published — the verified string carries no monthly figure
- Market
- $59–$1,300/mo is the full published spread on this site
- Structure
- Standard plan, self-directed low dose
No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.
235 of the 548 programs here price a small dose this way. Its two figures appear in the cards and again in the FAQ and they agree exactly, which is worth naming because several sellers here contradict themselves between those two places. But neither figure carries a billing period, so you know two numbers and not what either buys, and a separate access unlock reuses one of them for something else. No low-dose product and no dose published.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not confirmed
- Labs
- Not required
- Pricing
- Check plan terms
What it does well
- Its two prices are stated twice, in the cards and the FAQ, and they agree.
- Both figures are visible without an intake.
- Free shipping is included and stated on the same line as the price.
Pharmacy, labs and oversight
AbundRX does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
1 of 4 published openly
What AbundRX publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere on its own pages.
- Not published
- A price you can read before intakeThe figure appears only after an intake quiz, so it cannot be compared before signing up.
- Not published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
The reason to note this one is consistency. Its two figures appear in the product cards and again in the FAQ, in the same words, agreeing exactly — which sounds like the minimum and is not, because several sellers on this page contradict themselves between those two places. What is missing is the denominator. Neither figure carries a billing period: not a month, not a supply length, not a course, so a reader knows two numbers and not what either one buys. A separately advertised premium access unlock uses the same ninety-nine dollars for something else again, which makes the front page harder to read rather than easier. The care descriptions are hedged throughout in the language of what a treatment may do, and no milligram appears anywhere.
The honest cons
Neither figure states a billing period, so what it buys is unknown.
- The same number is used for a separate premium access unlock.
- No milligram appears against either figure.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
AbundRX is one of 548 low-dose GLP-1 programs compared on this site, and 299 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.
Also consider
Two more programs that price a small dose the way AbundRX does. Both are partners: we may earn a commission if you start care through these links.
Partner
Sprout Health
$149 sema · $199 tirz
Standard plan, self-directed low dose
FDA warning letter · Sprout Health · September 2025 · addressed to Sprout Health Partners LLC dba Sprout Health. Details in our review.
Partner
Bodybuilding Health+
$179/mo sema · $209/mo tirz
Standard plan, self-directed low dose
Where this sits
#329 of 548
Ordered with the companies that pay us first, and AbundRX is not one of them. A disclosed partition, not a score.
Compare all 548 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What microdosing GLP-1 costs
- Low dose vs full dose
- The true annual cost of a plan
- What a flat price costs at a low dose
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
RxSpan MD
$249/mo month to month ($199 on 6-mo)
- Vs median
- $74/mo above the $175 median
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Compounded by Belmar · Strive · Epiq Scripts · Casa Pharma Rx
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the RxSpan MD review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.